VirtualScopics, Inc. To Webcast Annual Meeting Of Shareholders On June 17, 2014; Five Members Of Senior Management To Provide Insight On The Company's Business And Future Outlook

ROCHESTER, N.Y., June 9, 2014 /PRNewswire/ -- VirtualScopics, Inc. VSCP, a leading provider of clinical trial imaging solutions, today announced it will webcast the 2014 Annual Meeting of Shareholders on Tuesday, June 17, 2014, beginning at 10 a.m.  The meeting will be held at the Country Club of Rochester, 2935 East Avenue, Rochester, New York, and is open to all VirtualScopics shareholders.  Information for this year's Annual Meeting, including the company's 2014 Annual Report, Form 10-K and Proxy Statement, can be found on the company's website.

During the meeting, presentations regarding VirtualScopics' business and future outlook will be made by five members of the company's senior management team: Eric Converse, interim Chief Executive Officer; Jim Groff, acting Chief Financial Officer; Erik Jensen, Vice President, Global Business Development and Marketing; Ed Ashton, Chief Scientific Officer; and Jon Riek, Chief Technical Officer.   

The webcast of the Annual Meeting, including featured slide presentations, can be accessed on the company's website at www.virtualscopics.com, under "investors" and "webcasts" or at http://www.investorcalendar.com/IC/CEPage.asp?ID=172786.  A replay of the webcast and slide presentations will be available one hour after the conclusion of the Annual Meeting of Shareholders and will be archived on the company's website.

About VirtualScopics, Inc.
VirtualScopics, Inc. VSCP is a leading provider of clinical trial imaging solutions to accelerate drug and medical device development.  For risk-averse, time-constrained Clinical Trial Study Teams, Medical Directors and Imaging Scientists who require quality imaging data delivered on-time, within budget and on a consistent basis, VirtualScopics' clinical trial imaging solutions are an inspired true exception to commonly accepted services provided by other clinical trial imaging providers.  Because of the scientific and operational flexibility and responsiveness they can offer, VirtualScopics' clinical trial imaging solutions deliver special performance advantages compared to other image service providers that offer common, every day clinical trial imaging services.  For more information about VirtualScopics, Inc. please visit www.virtualscopics.com.

For more information, contact:
Donna N. Stein, APR, Fellow PRSA
Managing Partner, Donna Stein & Partners
315-361-4672
dstein1@twcny.rr.com

SOURCE VirtualScopics, Inc.